1'-acetyl-1-(5-chloro-1,3-thiazol-2-yl)-N-(2-methoxyethyl)-N-methylspiro[2H-indole-3,3'-pyrrolidine]-5-sulfonamide
C20H25ClN4O4S2 — CID 151171230
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1'-acetyl-1-(5-chloro-1,3-thiazol-2-yl)-N-(2-methoxyethyl)-N-methylspiro[2H-indole-3,3'-pyrrolidine]-5-sulfonamide
1'-acetyl-1-(5-chloro-1,3-thiazol-2-yl)-N-(2-methoxyethyl)-N-methylspiro[2H-indole-3,3'-pyrrolidine]-5-sulfonamide (PubChem CID 151171230) has the molecular formula C20H25ClN4O4S2 and a molecular weight of 485.03 g/mol. Its IUPAC name is 1'-acetyl-1-(5-chloro-1,3-thiazol-2-yl)-N-(2-methoxyethyl)-N-methylspiro[2H-indole-3,3'-pyrrolidine]-5-sulfonamide.
Molecular Properties
| Compound Name | 1'-acetyl-1-(5-chloro-1,3-thiazol-2-yl)-N-(2-methoxyethyl)-N-methylspiro[2H-indole-3,3'-pyrrolidine]-5-sulfonamide |
|---|---|
| PubChem CID | 151171230 |
| Molecular Formula | C20H25ClN4O4S2 |
| Molecular Weight | 485.03 g/mol |
| Exact Mass | 484.10 |
| IUPAC Name | 1'-acetyl-1-(5-chloro-1,3-thiazol-2-yl)-N-(2-methoxyethyl)-N-methylspiro[2H-indole-3,3'-pyrrolidine]-5-sulfonamide |
| SMILES | COCCN(C)S(=O)(=O)c1ccc2c(c1)C1(CCN(C(C)=O)C1)CN2c1ncc(Cl)s1 |
| InChI | InChI=1S/C20H25ClN4O4S2/c1-14(26)24-7-6-20(12-24)13-25(19-22-11-18(21)30-19)17-5-4-15(10-16(17)20)31(27,28)23(2)8-9-29-3/h4-5,10-11H,6-9,12-13H2,1-3H3 |
| InChIKey | NCHYBNFGNHJIFK-UHFFFAOYSA-N |
| XLogP | 2.71 |
| TPSA | 83.05 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 485.03 |
| LogP ≤ 5 | 2.71 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151171230 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.